![@Mithra Announces US Patent Allowance for the Use of Estetrol as Emergency Contraceptive](https://wallonia.be//sites/default/files/2017-01-18-press-release-V2-1030x686.jpg)
Mithra Pharmaceuticals (Liege), a company focused on women’s health, announces that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Application Serial Number 14/238,310 a patent which covers the use of Estetrol (E4) as an emergency contraceptive.
The patent specifically covers E4, a naturally occurring estrogen, as a potential new emergency contraception option where E4 is used alone .
This new method differs from currently approved emergency contraceptive which includes progestin only pills and combined estrogen progestin pills.
Francois Fornieri, CEO of Mithra Pharmaceuticals , said : " With an improved safety profile compared to the current generation of estrogens, E4 has the potential to revolutionalize the contraceptive market. This patent allowance further strengthen s our US intellectual property position and we look forward to further developing E4 in emergency oral contraceptive applications."
Linked articles
Related articles
![The chef Ricarda Grommes The chef Ricarda Grommes](https://wallonia.be//sites/default/files/styles/medium/public/Belgaimage-91082126.jpg?itok=DAlaYPU7)
Paris 2024 Olympics: chef Ricarda Grommes to represent gastronomy of Wallonia at Belgium House
![](https://wallonia.be//sites/default/files/styles/medium/public/thumbnail_image001.jpg?itok=cwG9z0bA)
Take advantage of the holidays to read the new WAB magazine Summer 2024!
![](https://wallonia.be//sites/default/files/styles/medium/public/JO_wallonia.jpg?itok=BnAjYdaW)
Paris Olympics: Wallonia-Brussels days
![](https://wallonia.be//sites/default/files/styles/medium/public/AdobeStock_778408841_1.jpg?itok=9JGOO22P)